Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 5/20 | 0.60 |
| ▸ | PRKCG | P05129 | 5/20 | 0.60 |
| ▸ | PRKD3 | O94806 | 4/20 | 0.60 |
| ▸ | PRKCB | P05771 | 4/20 | 0.60 |
| ▸ | PRKCH | P24723 | 4/20 | 0.60 |
| ▸ | PRKCI | P41743 | 4/20 | 0.60 |
| ▸ | PRKCE | Q02156 | 4/20 | 0.60 |
| ▸ | PRKCQ | Q04759 | 4/20 | 0.60 |
| ▸ | PRKCZ | Q05513 | 4/20 | 0.60 |
| ▸ | PRKCD | Q05655 | 4/20 | 0.60 |
| ▸ | PRKD1 | Q15139 | 4/20 | 0.60 |
| ▸ | VAV1 | P15498 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phorbol SCHEMBL15976176 | 1.00 | PRKCA (0.60) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL2329457 | 1.00 | PRKCA (0.60) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL1733926 | 1.00 | PRKCA (0.60) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL3403135 | 1.00 | PRKCA (0.60) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL5667270 | 1.00 | PRKCA (0.60) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL12950512 | 1.00 | PRKCA (0.60) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL8190878 | 1.00 | PRKCA (0.60) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL23880303 | 0.99 | PRKCA (0.59) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL5310296 | 0.99 | PRKCA (0.59) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL19435231 | 0.98 | PRKCA (0.59) | PRKCAPRKCGPRKD3PRKCBPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 44660 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3787613-B1 | PKC ACTIVATION FOR USE IN TREATING EARLY ONSET SPORADIC PARKINSON'S DISEASE | CEDARS SINAI MEDICAL CENTER (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4271199-B1 | PROCESS OF PREPARING HIGH PROTEIN GUAR MEAL | SHREE RAM INDIA GUMS PVT LTD (IN) | 2026-02-25 | — | — | EP | claimed |
| EP-3995139-B1 | COMPOSITION FOR USE IN TREATING CANCER | UNIV GEORGIA STATE RES FOUND (US) | 2026-02-18 | — | — | EP | claimed |
| WO-2025235403-A1 | DIFFERENTIATION OF PANCREATIC ISLET CELLS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-11-13 | — | — | WO | claimed |
| EP-4358979-B1 | METHOD FOR OBTAINING A PLATELET DERIVED SECRETOME AND USES THEREOF | FUNDACION PARA LA INVESTIG E INNOVACION BIOSANITARIA DEL PRINCIPADO DE ASTURIAS FINBA (ES) | 2025-10-08 | — | — | EP | claimed |
| EP-4244622-B1 | METHOD FOR DIAGNOSING AND MONITORING SEPSIS | SEROXO LTD (GB) | 2025-08-13 | — | — | EP | claimed |
| EP-4168585-B1 | METHOD OF DETECTING INFECTION WITH PATHOGENS CAUSING TUBERCULOSIS | MIKROGEN GMBH (DE) | 2025-07-30 | — | — | EP | claimed |
| EP-4573367-A2 | POINT-OF-CARE ON-CHIP IGRA DEVICE AND METHOD FOR MEASURING SPECIFIC T CELL ACTIVATION | The Administrators of The Tulane Educational Fund (US) | 2025-06-25 | — | — | EP | claimed |
| WO-2025122943-A1 | COMPOSITIONS AND METHODS FOR ENHANCED PAYLOAD REGULATION USING NUCLEAR FACTOR OF ACTIVATED T CELLS (NFAT) RESPONSE ELEMENTS | OBSIDIAN THERAPEUTICS, INC. (US) | 2025-06-12 | — | — | WO | claimed |
| US-12311024-B2 | Cancer cell-targeted drug delivery carrier and composition for promoting photo-thermal treatment effects, both of which contain M1 macrophages as active ingredient | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2025-05-27 | — | — | US | claimed |
| EP-0153357-A1 | PROCESS FOR PRODUCING HUMAN INTERLEUKINE 1 AND RELATED DRUGS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1985-09-04 | — | — | EP | claimed |
| US-4518526-A | Purification and activity assurance of precipitated heterologous proteins | GENENTECH, INC. (US) | 1985-05-21 | — | — | US | claimed |
| EP-0135797-A2 | Process for preparing lymphotoxin and lymphotoxin-mRNA | BOEHRINGER INGELHEIM INTERNATIONAL GmbH (DE) | 1985-04-03 | — | — | EP | claimed |
| WO-1985000830-A1 | PROCESS FOR PRODUCING HUMAN INTERLEUKINE 1 AND RELATED DRUGS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE M (FR) | 1985-02-28 | — | — | WO | claimed |
| EP-0117060-A2 | Methods of screening and amplification in eukaryotic host cells, and nucleotide sequences and expression vectors for use therein | GENENTECH, INC. (US) | 1984-08-29 | — | — | EP | claimed |
| EP-0117059-A2 | Methods for producing human tPA and expression vectors therefor | GENENTECH, INC. (US) | 1984-08-29 | — | — | EP | claimed |
| US-4468328-A | Purification of 12-O-tetradecanoylphorbol-13-acetate, phorbol, and 4α- | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILL. (US) | 1984-08-28 | — | — | US | claimed |
| EP-0108919-A2 | Process for producing T cell-activating factor | Okai, Yasuji (JP) | 1984-05-23 | — | — | EP | claimed |
| US-4376821-A | Production of human IFN-gamma (immune) interferon | MELOY LABORATORIES, INC. (US) | 1983-03-15 | — | — | US | claimed |
| US-4376822-A | LEUKOCYTES MODULATED WITH MEZEREIN OR 12,13 PHORBOL DIBUTYRATE | MELOY LABORATORIES, INC. (US) | 1983-03-15 | — | — | US | claimed |